A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
Clinical trial NCT00875693 · COMPLETED
Trial details
- NCT number
- NCT00875693
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-02
- Primary completion
- 2014-06-30
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.